Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active β-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c

The Rv3588c gene product of Mycobacterium tuberculosis, a β-carbonic anhydrase (CA, EC 4.2.1.1) denominated here mtCA 2, shows the highest catalytic activity for CO 2 hydration ( k cat of 9.8 × 10 5 s −1, and k cat/ K m of 9.3 × 10 7 M −1 s −1) among the three β-CAs encoded in the genome of this pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2009-12, Vol.19 (23), p.6649-6654
Hauptverfasser: Carta, Fabrizio, Maresca, Alfonso, Covarrubias, Adrian Suarez, Mowbray, Sherry L., Jones, T. Alwyn, Supuran, Claudiu T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Rv3588c gene product of Mycobacterium tuberculosis, a β-carbonic anhydrase (CA, EC 4.2.1.1) denominated here mtCA 2, shows the highest catalytic activity for CO 2 hydration ( k cat of 9.8 × 10 5 s −1, and k cat/ K m of 9.3 × 10 7 M −1 s −1) among the three β-CAs encoded in the genome of this pathogen. A series of sulfonamides/sulfamates was assayed for their interaction with mtCA 2, and some diazenylbenzenesulfonamides were synthesized from sulfanilamide/metanilamide by diazotization followed by coupling with amines or phenols. Several low nanomolar mtCA 2 inhibitors have been detected among which acetazolamide, ethoxzolamide and some 4-diazenylbenzenesulfonamides ( K Is of 9–59 nM). As the Rv3588c gene was shown to be essential to the growth of M. tuberculosis, inhibition of this enzyme may be relevant for the design of antituberculosis drugs possessing a novel mechanism of action.
ISSN:0960-894X
1464-3405
1464-3405
DOI:10.1016/j.bmcl.2009.10.009